A. Ari Hakimi

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

70h-index29.3kcitations540works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(359), Renal and related cancers(188), Cancer Genomics and Diagnostics(165), Bladder and Urothelial Cancer Treatments(98), Ferroptosis and cancer prognosis(69)

Publications540 total

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
CA A Cancer Journal for Clinicians·2025Open Access
Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma
Cancers·2025Open Access
Supplementary Tables S6-S8 from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade
2025Open Access
Supplementary Tables S1-S5 from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade
2025Open Access
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs
Nature Communications·2025· 1 citedOpen Access
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
European Urology·2025
Hypoxia and tumor associated macrophages shape response to immune and angiogenesis-targeted therapies in metastatic clear cell renal cell carcinoma 3738
The Journal of Immunology·2025Open Access
Influence of sex on immunosurveillance and metastatic tropism in novel mouse models of clear cell renal cell carcinoma 4060
The Journal of Immunology·2025Open Access
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium
The Lancet Oncology·2025· 4 citedOpen Access
47TCF1+ CD4+ T cells mediate response to anti-CTLA-4 therapy in a sarcomatoid RCC mouse model
The Oncologist·2025Open Access
34Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma
The Oncologist·2025Open Access
A health-system-scale, episode-resolved multimodal atlas of cancer cachexia
2025· 1 citedOpen Access
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell Carcinoma
European Urology·2025· 2 citedOpen Access
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma
Urologic Oncology Seminars and Original Investigations·2025
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma—An Observational Prospective Multicentre Diagnostic Test Cohort Study
European Urology Oncology·2025· 3 citedOpen Access
Noninvasive Ventilation on Acute Hypoxemic Respiratory Failure: Analysis of Therapeutic Impact in an Observational study
Batna Journal of Medical Sciences (BJMS)·2025Open Access
Dissecting the molecular landscape of fumarate hydratase-deficient RCC: towards precision oncology
Nature Reviews Urology·2025
Biomarkers for renal cell carcinoma — a pragmatic approach
Nature Reviews Urology·2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma
2025Open Access
MP14-09 THE NATURAL HISTORY OF METASTATIC CLEAR-CELL RENAL CELL CARCINOMA MANAGED WITH LOCAL THERAPY ALONE: SHOULD EVERYONE BE RECEIVING ADJUVANT IMMUNOTHERAPY?
The Journal of Urology·2025
page 1 of 27Next →

Frequent Co-authors

James J. Hsieh(22), Robert J. Motzer(16), Timothy A. Chan(16), Martin H. Voss(15), Paul Russo(15), Victor E. Reuter(15), Michael F. Berger(12), Ying‐Bei Chen(12), Chris Sander(10), Luc G.T. Morris(9), Jonathan Coleman(9), Nikolaus Schultz(9), Fengshen Kuo(9), Nadeem Riaz(8), Emily H. Cheng(8), Satish K. Tickoo(8), Ahmet Zehir(7), Marc Ladanyi(7), David B. Solit(7), Irina Ostrovnaya(7)